Prostate-Specific Antigen (PSA) Testing Market: Overview
Prostate-specific antigen, or PSA, is measured in human blood through a PSA test. A man's reproductive system includes a tiny gland called the prostate that is situated below the bladder. A glycoprotein called prostate-specific antigen is secreted by epithelial prostatic cells. PSA either interacts with other cells or is free to move around the body.
A PSA test is a blood test primarily used to screen for prostate cancer. Your blood is examined for prostate-specific antigen during the test (PSA). Both malignant and non-cancerous cells in the prostate, a tiny gland located behind the bladder in men, produce a protein known as PSA. Since it is mostly prevalent in semen, it can also be detected in the prostate. In the body's blood, PSA is typically found in trace amounts. If the PSA level is elevated, a PSA test might be helpful to identify prostate cancer. Other problems, such an enlarged or inflammatory prostate, can also raise PSA readings. As a result, it can be difficult to interpret a high PSA score.
Prostate Specific Antigen (PSA) Testing Market: Segmentation Analysis
Prostate Specific Antigen (PSA) Testing Market by test procedure
- Preliminary Tests
- Confirmatory Tests
Due to an increment in the recurrence of prostate cancer, the Preliminary Tests segment is probably going to hold the largest market share. The American Institute for Cancer Research asserts that the far and wide accessibility of PSA screening has helped early recognition and therapy, bringing about higher endurance rates. PSA testing are reliable to identify the undetected and small lesions that could possibly advance to a further developed phase of disease. Most men beyond 50 years old, as well as those belonging to the risk group should go for these tests since it can help diagnosing the illness before genuine side effects emerge.
Prostate Specific Antigen (PSA) Testing Market by test type:
- Total Prostate Specific Angiten Test (tPSA)
- Complex Prostate Specific Antigen Test (cPSA)
- Free Prostate Specific Antigen Test (fPSA)
- Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test (PSA RT-PCR)
- PCA3Test
- Trans-rectal Ultrasound
- Biopsy
Among these, the biopsy segment is anticipated to grow significantly over the forecast period owing to rising prevalence of cancer across the globe.
Prostate Specific Antigen (PSA) Testing Market by assays type:
- Radioimmunoassay (RIA)
- Enzyme immunoassay (EIA)
Prostate Specific Antigen (PSA) Testing Market by application:
- Screening
- Post-treatment monitoring
- Others
Among these, post treatment monitoring segment is anticipated to gain traction over the forecast duration due to rising concerns about the after effect of medical treatment procedures like surgeries.
Prostate Specific Antigen (PSA) Testing Market: Geographical ambit
In term of geography, the worldwide market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among the areas, North America is anticipated to dominate the market and is probably going to be firmly trailed by Europe as prostate cancer is the most common type of cancer found in men in these regions.
The ensuing high death rate in various developed countries and rising frequency of prostate cancer in this area are the elements are positively swaying the dynamics of Prostate Specific Antigen (PSA) Testing Market during the forecast duration. Likewise, rising government initiatives aiming at the quick diagnosis of prostate cancer among the masses and advancement in medical services are accounted to support the progression of Prostate Specific Antigen (PSA) Testing Market in the region.
Get Free Sample:- https://wemarketresearch.com/sample-request/prostate-specific-antigen-(psa)-testing-market/28/
Top Key Players:-
- Bayer AG.
- Beckman Coulter Inc.
- GE Healthcare
- GlaxoSmithKline plc.
- Novartis Pharma AG.
- UroLogix Inc.
- Bristol - Myers Squibb Company
- AstraZeneca plc.
- MDx Health
- Myriad Genetics Inc
- Hoffman-La Roche AG
- Siemens Healthineers AG
- OPKO Health Inc.
- Genomic Health
- DiaSorin
- Roche
- PerkinElmer
- Tosoh
- Ortho Clinical
- Fujirebio
- Mediwatch (LABORIE)
- BodiTech
Interested in purchasing this Report? Click here:- https://wemarketresearch.com/purchase/prostate-specific-antigen-(psa)-testing-market/28/?license=single
Frequently Asked Questions (FAQ):
- Which product segment grabbed the largest share in the India Prostate Specific Antigen (PSA) Testing market?
- How is the competitive scenario of the India Prostate Specific Antigen (PSA) Testing market?
- Which are the key factors aiding the India Prostate Specific Antigen (PSA) Testing market growth?
- Which region holds the maximum share in the India Prostate Specific Antigen (PSA) Testing market?
- What will be the CAGR of the India Prostate Specific Antigen (PSA) Testing market during the forecast period?
- Which application segment emerged as the leading segment in the India Prostate Specific Antigen (PSA) Testing market?
- Which are the prominent players in the India Prostate Specific Antigen (PSA) Testing market?
About We Market Research
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact Us:
We Market Research
Phone: +1(929)-450-2887
Email: [email protected]
